Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fox

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Neurology|September 4, 2016
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysisDuncan Wilson, Andreas Charidimou, Gareth Ambler, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacementsAnthony J Roecker, Swati P Mercer, Jeffrey M Bergman, et al.
Brain Research|September 3, 2011
TASK-3 as a potential antidepressant targetAnthony L Gotter, Vincent P Santarelli, Scott M Doran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in ratsSteven V Fox, Anthony L Gotter, Spencer J Tye, et al.
Chemmedchem|September 15, 2011
Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3)Craig A Coburn, Yunfu Luo, Mingxiang Cui, et al.
BMC Neuroscience|August 29, 2013
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy thresholdAnthony L Gotter, Christopher J Winrow, Joseph Brunner, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
The Science of the Total Environment|November 24, 1999
Marine radioactivity assessment of Mururoa and Fangataufa atollsP P Povinec, D Woodhead, P Blowers, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexantIzzat T Raheem, Michael J Breslin, Joseph Bruno, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Neurology|September 4, 2016
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysisDuncan Wilson, Andreas Charidimou, Gareth Ambler, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2015
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacementsAnthony J Roecker, Swati P Mercer, Jeffrey M Bergman, et al.
Brain Research|September 3, 2011
TASK-3 as a potential antidepressant targetAnthony L Gotter, Vincent P Santarelli, Scott M Doran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in ratsSteven V Fox, Anthony L Gotter, Spencer J Tye, et al.
Chemmedchem|September 15, 2011
Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3)Craig A Coburn, Yunfu Luo, Mingxiang Cui, et al.
BMC Neuroscience|August 29, 2013
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy thresholdAnthony L Gotter, Christopher J Winrow, Joseph Brunner, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
The Science of the Total Environment|November 24, 1999
Marine radioactivity assessment of Mururoa and Fangataufa atollsP P Povinec, D Woodhead, P Blowers, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexantIzzat T Raheem, Michael J Breslin, Joseph Bruno, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Pageof 10